Intermittent Levetricetam in Treatment of Febrile Convulsions

• Status: Not yet recruiting
• Trial end date: 2024-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The American Academy of Pediatrics (AAP) in 2011 published a clinical practice guideline defining a febrile seizure as "a seizure accompanied by fever (temperature ≥ 100.4°F or 38°C by any method), without central nervous system infection, that occurs in infants and children 6 through 60 months of age." Febrile seizures are further classified as simple (generalized in onset, last less than 15 minutes, and do not occur more than once in 24 hours.) or complex (FS duration longer than 15 min, repeated convulsions within the same day, and focal seizure activity or focal findings during the postictal period.).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Diazepam; Levetiracetam

Criteria

Inclusion Criteria:

• Included children 6 months to 36 months with febrile seizures after exclusion of CNS infections .

Exclusion Criteria:

• Non-febrile seizures

• Head trauma

• CNS infections

• Known metabolic diseases

• Known genetic disorders

• Developmental delay